An international multidisciplinary consensus statement on MAFLD and the risk of CVD-Reference-Cited by-同舟云学术

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

Published:2023-05-19 Issue:4 Volume:17 Page:773-791
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Zhou Xiao-Dong,Targher Giovanni,Byrne Christopher D.,Somers Virend,Kim Seung Up,Chahal C. Anwar A.,Wong Vincent Wai-Sun,Cai Jingjing,Shapiro Michael D.,Eslam Mohammed,Steg Philippe Gabriel,Sung Ki-Chul,Misra Anoop,Li Jian-Jun,Brotons Carlos,Huang Yuli,Papatheodoridis George V.,Sun Aijun,Yilmaz Yusuf,Chan Wah Kheong,Huang Hui,Méndez-Sánchez Nahum,Alqahtani Saleh A.,Cortez-Pinto Helena,Lip Gregory Y. H.,de Knegt Robert J.,Ocama Ponsiano,Romero-Gomez Manuel,Fudim Marat,Sebastiani Giada,Son Jang Won,Ryan John D.,Ikonomidis Ignatios,Treeprasertsuk Sombat,Pastori Daniele,Lupsor-Platon Monica,Tilg Herbert,Ghazinyan Hasmik,Boursier Jerome,Hamaguchi Masahide,Nguyen Mindie H.,Fan Jian-Gao,Goh George Boon-Bee,Al Mahtab Mamun,Hamid Saeed,Perera Nilanka,George Jacob,Zheng Ming-Hua^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-023-10543-8.pdf

Reference156 articles.

1. Younossi Z, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD) 2016;64:73–84

2. Chalasani N, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, MD) 2018;67:328–357

3. Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 2020;73:202–209

4. Zhang XL, Fan JG, Wei L, Shi JP, Zheng MH. Promoting the term MAFLD: China in action. Lancet Gastroenterol Hepatol 2022;7:598

5. Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 2020;158:1999-2014.e1

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: an international multidisciplinary expert consensus;Metabolism;2024-09

2. MASLD-Related Hepatocarcinoma: Special Features and Challenges;Journal of Clinical Medicine;2024-08-08

3. Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals;Current Obesity Reports;2024-08-07

4. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier;Hepatology International;2024-08-06

5. Current status and future trends of the global burden of MASLD;Trends in Endocrinology & Metabolism;2024-08